“…The basic residues (LYS0019, LYS0115, and ARG0118) of the membrane-docking site (MDoS) promote protein–membrane binding, while the hydrophobic ones (LEU0122, PRO0125, and PHE0126), located at the membrane-disrupting site (MDiS), induce membrane destabilization, consequently resulting in cell death , (see Figure b). Thus, in order to avoid recognition of the membrane, a number of compounds that bind MDoS and/or MDiS have been proposed. ,,− Among these, varespladib is a synthetic inhibitor of human-secreted group IIA PLA 2 , capable of inhibiting PLA 2 enzymes . Based on homology between the human group IIA PLA 2 and PLA 2 proteins found in snake venoms, varespladib was tested in a large panel of toxins and presented potent inhibition against PLA 2 activity .…”